Susquehanna International Group, LLP Anixa Biosciences Inc Transaction History

Susquehanna International Group, LLP

$688 Billion
Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 16,803 shares of ANIX stock, worth $51,081. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,803

Previous 195,171 91.39%

Holding current value

$51,081

Previous $558,000 90.14%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$2.38 - $3.75 $424,515 - $668,880	-178,368 Reduced 91.39%	16,803 $55,000
Q1 2025 May 14, 2025	SELL	$2.13 - $3.29 $184,291 - $284,657	-86,522 Reduced 30.71%	195,171 $558,000
Q4 2024 Feb 14, 2025	BUY	$2.48 - $3.97 $459,655 - $735,819	185,345 Added 192.37%	281,693 $698,000
Q3 2024 Nov 14, 2024	SELL	$2.21 - $3.48 $35,459 - $55,836	-16,045 Reduced 14.28%	96,348 $303,000
Q2 2024 Aug 15, 2024	SELL	$2.21 - $3.35 $505,113 - $765,669	-228,558 Reduced 67.04%	112,393 $248,000
Q1 2024 May 07, 2024	BUY	$3.08 - $5.02 $824,355 - $1.34 Million	267,648 Added 365.13%	340,951 $1.06 Million
Q4 2023 Feb 14, 2024	BUY	$2.85 - $4.19 $104,438 - $153,542	36,645 Added 99.96%	73,303 $284,000
Q3 2023 Nov 14, 2023	SELL	$2.97 - $3.87 $31,482 - $41,022	-10,600 Reduced 22.43%	36,658 $119,000
Q2 2023 Aug 11, 2023	SELL	$3.0 - $5.97 $325,578 - $647,900	-108,526 Reduced 69.66%	47,258 $151,000
Q1 2023 May 16, 2023	BUY	$3.86 - $5.0 $327,177 - $423,805	84,761 Added 119.34%	155,784 $669,000
Q4 2022 Feb 14, 2023	BUY	$3.78 - $5.81 $117,614 - $180,778	31,115 Added 77.97%	71,023 $301,000
Q3 2022 Nov 14, 2022	BUY	$2.81 - $6.15 $62,154 - $136,031	22,119 Added 124.34%	39,908 $196,000
Q2 2022 Aug 15, 2022	SELL	$2.55 - $4.1 $3,853 - $6,195	-1,511 Reduced 7.83%	17,789 $54,000
Q4 2021 Feb 14, 2022	SELL	$2.88 - $5.5 $76,625 - $146,333	-26,606 Reduced 57.96%	19,300 $57,000
Q3 2021 Nov 15, 2021	BUY	$3.57 - $5.6 $103,530 - $162,400	29,000 Added 171.54%	45,906 $219,000
Q2 2021 Aug 11, 2021	BUY	$3.46 - $4.92 $58,494 - $83,177	16,906 New	16,906 $66,000

Others Institutions Holding ANIX

# of Institutions

Shares Held

5.34M

Call Options Held

14.1K

Put Options Held

12.1K

View Full List

About Anixa Biosciences Inc

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $93.2M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

More about ANIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Anixa Biosciences Inc Transaction History